Company Profile For Aurobindo Pharma Ltd
Aurobindo Pharma Ltd (ARBN.BO) (Bombay Stock Exchange)
sector: Healthcare ·
industry: Pharmaceuticals - Generic & Specialty ·
Overview
Aurobindo Pharma Limited (APL) is an integrated pharmaceutical company manufacturing active pharmaceutical ingredients (APIs), intermediates and generic formulations. The Company has a product portfolio of 300 products. Major therapeutic segments covered include cardio vascular, neuroscience, anti-retroviral, gastro-intestinal, anti-infective, pain management and osteoporosis. The Company has joint control over Cephazone Pharma LLC for production of sterile and non-sterile cephalosporins and Aurosal Pharmaceuticals LLC, which is engaged in the development, manufacturing and distribution of pharmaceuticals products.
Quick Financial Synopsis
BRIEF: For the six months ended 30 September 2009, Aurobindo Pharma Limited's revenues increased 25% to RS17.35B. Net income totaled RS2.70B, vs. a loss of RS2.20M. Revenue reflects an increase in income from operation. Net income reflects an increase in other income, presence of foreign exchange gain against a loss and improved operating margin. Aurobindo Pharma Limited is engaged in manufacturing medicines.
Company Address
Aurobindo Pharma Ltd
Plot No. 2, Maitrivihar
Ameerpet
Hyderabad 500 038
P: +9140.55725000
F: +9140.23741080
Plot No. 2, Maitrivihar
Ameerpet
Hyderabad 500 038
P: +9140.55725000
F: +9140.23741080
Total Employees
6300
Find Out More About ARBN.BO
Market Update
India
US
UK- Asia
- Most Actives
Commodities
| Commodity | Last | Pct Chg | Trade Date/Time |
|---|---|---|---|
| Oil | 76.38 | -1.41% | 11/24 23:30 IST |
| Gold | 1167.0 | +0.20% | 11/24 23:10 IST |
